This message contains images. If you don't see images, click here to view.
Advertise in this news brief.




Text Version    RSS    Subscribe    Unsubscribe    Archive    Media Kit September 08, 2014

Education   News & Publications   Grants & Research   Advocacy   Resources   About ASTS

 


Study outlines risk factors for solid organ cancers after liver transplantation
The Oncology Report
The indication for liver transplant, the selection of immunosuppression therapy and smoking status influence the long-term risk of new solid organ malignancies after liver transplantation, Dr. Sebastian Rademacher reported at the 2014 World Transplant Congress. Multivariate analysis showed that recipients' risk of a new solid organ cancer was elevated for those who had a history of smoking (1.89). Risk was reduced for recipients who received tacrolimus, compared with cyclosporine A (0.56), and for patients who had primary biliary cirrhosis/primary sclerosing cholangitis (0.47) or hepatitis C infection (0.21) as the indication for transplantation.
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
READ MORE




SOCIETY NEWS


ASTS Recognition Awards nominations due Sept. 15
ASTS
Has a faculty member, mentor or peer had a positive influence on your career? Say thank you by nominating them for an ASTS Recognition Award!
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
READ MORE


UNOS liver public forum
ASTS
ASTS encourages its members to participate in the discussions surrounding the OPTN/UNOS concept document proposing changes to liver allocation. The OPTN/UNOS Liver and Intestinal Organ Transplantation Committee is sponsoring a forum to discuss this concept document on Sept. 16, 2014. You may participate through a live teleconference.
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
READ MORE


ASTS history book available
ASTS
If you weren't able to attend the World Transplant Congress and pick up the book chronicling the past 20 years of ASTS history, you can still get a copy! One free copy is available to ASTS members, and non-members can purchase a copy in the ASTS Store.
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article


TOP NEWS


Parvovirus associated fulminant hepatic failure and aplastic anemia treated successfully with liver and bone marrow transplantation
American Journal of Transplantation (login required)
Aplastic anemia (AA) has been observed in nearly a third of patients undergoing liver transplantation (LT) for non-A-E fulminant hepatic failure (FHF). Few of these patients have been successfully managed with sequential LT and bone marrow transplantation (BMT). No causative agent has been identified for the FHF or AA in these reported cases.
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
READ MORE




Toward personalized medicine for kidney transplant recipients
UCSF
UC San Francisco is the lead institution on a new seven-year, $17 million multicenter study funded by the National Institutes of Health to determine if certain immune system cells and/or a drug now used for treating rheumatoid arthritis can be effective in improving and maintaining the long-term health of kidney transplant recipients. The goal of this study is to reduce or eliminate inflammation in kidney transplants and prevent the associated decline in function, thereby maximizing long-term organ survival.
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
READ MORE


Risk of metabolic complications in kidney transplantation after conversion to mTOR inhibitor: A systematic review and meta-analysis
American Journal of Transplantation (login required)
Mammalian target of rapamycin (mTOR) inhibitors have been used in transplantation with the hope of minimizing calcineurin inhibitor (CNI)-induced nephrotoxicity. However, mTOR inhibitors are also associated with a range of side effects, including metabolic complications. We aimed to determine the risks of metabolic complications after the conversion from CNI to mTOR inhibitor postkidney transplant. A systematic search in PubMed up to September 2013 identified nine relevant trials (a total of 2323 patients). The primary end points were the relative risks (RRs) of new-onset diabetes after transplant (NODAT) and hypercholesterolemia.
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
READ MORE


$17 million multi-institutional grant to maximize kidney transplant survival
UAB News
The University of Alabama at Birmingham is participating in a new seven-year, $17 million multicenter study funded by the National Institutes of Health to determine whether certain immune system cells and/or a drug used for treating rheumatoid arthritis can improve and maintain the long-term health of kidney transplant recipients. The goal of the study is to reduce or eliminate inflammation in kidney transplants and prevent the associated decline in graft function, thereby maximizing long-term organ survival. It will involve two clinical trials in parallel by researchers at four sites around the country.
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
READ MORE


TRENDING ARTICLES
Missed our previous issues? See which articles your colleagues read most.

    Consensus conference on training in HBP surgery (ASTS)
Through a glass darkly: Seeking clarity in preventing late kidney transplant failure (Journal of the American Society of Nephrology)
Management of hepatitis C in kidney transplant patients: On the cusp of change (American Journal of Transplantation)
UCSF 1st in nation to join with Walgreens in blood pressure testing program for living kidney donors, potential donors (UCSF)
Study: Liver transplants from living donors lead to better survival (By Karen Zabel)

Don't be left behind. Click here to see what else you missed.


Long-term effect of childhood liver transplantation on body cell mass
Liver Transplantation
Malnutrition is common in end-stage liver disease, but a correction after transplantation is expected. Body cell mass (BCM) assessment using total body potassium measurements is considered the gold standard for assessing nutritional status. The aim of this study was to examine the BCM and, therefore, nutritional status of long-term survivors after childhood liver transplantation.
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
READ MORE


Immunosuppressive effects of erythropoietin on human alloreactive T cells
Journal of the American Society of Nephrology (login required)
Correction of anemia with erythropoietin (EPO) is associated with improved kidney transplant outcomes. Emerging evidence, predominantly from animal models, indicates that these observations may be erythropoiesis-independent and that EPO exhibits immunosuppressive properties. This study examined the effects of EPO on human T-cell alloimmunity by first documenting that CD4+ and CD8+ T cells express EPO receptor (EPO-R) on their surfaces.
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
READ MORE


British hospital performs world's first revived liver transplant
The Telegraph
A British hospital has become the first in the world to use a groundbreaking technique to successfully revive a liver for transplant. Surgeons at Birmingham's Queen Elizabeth Hospital are the first to successfully transplant a liver into a patient using a "warm blood" machine to revive the organ after it was transported in an ice box.
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
READ MORE


Ambulatory ECMO as a bridge to lung transplant in a previously well pediatric patient with ARDS
Pediatrics
Extracorporeal membrane oxygenation (ECMO) is increasingly implemented in patients with end-stage pulmonary disease as a bridge to lung transplant. Several centers have instituted an approach that involves physical rehabilitation and ambulation for patients supported with ECMO. Recent reports describe the successful use of ambulatory ECMO in patients with chronic respiratory illnesses being bridged to lung transplant.
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
READ MORE


 

ASTS NewsBrief
Colby Horton, Vice President of Publishing, 469.420.2601
Download media kit

Esther Cho, Content Editor, 469.420.2671   
Contribute news

This edition of the ASTS NewsBrief was sent to ##Email##. To unsubscribe, click here. Did someone forward this edition to you? Subscribe here -- it's free!
Recent issues
Aug. 25, 2014
Aug. 11, 2014
July 28, 2014



7701 Las Colinas Ridge, Ste. 800, Irving, TX 75063